Viscosupplementation in patients with severe osteoarthritis of the knee: six month follow-up of a randomized, double-blind clinical trial
Purpose To analyze the early outcomes of viscosupplementation in patients with severe knee osteoarthritis. Method A randomized, double-blind clinical trial of 143 knees divided into three groups: Group 1 – intra-articular injection of triamcinolone; Group 2 – hylan GF20; and Group 3 – triamcinolone...
Saved in:
Published in: | International orthopaedics Vol. 41; no. 11; pp. 2273 - 2280 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01-11-2017
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
To analyze the early outcomes of viscosupplementation in patients with severe knee osteoarthritis.
Method
A randomized, double-blind clinical trial of 143 knees divided into three groups: Group 1 – intra-articular injection of triamcinolone; Group 2 – hylan GF20; and Group 3 – triamcinolone + hylan GF20. Outcomes were evaluated using Lysholm and KSS scores before treatment and after one, three and six months.
Results
Within-group comparisons revealed improvements in Lysholm scores in all groups in the one month evaluation relative to pre-treatment levels (
p
< 0.01). This improvement was maintained in the third month after treatment (
p
> 0.05). Scores at six months were significantly lower than those observed in the previous follow-up assessments (
p
< 0.05), but still higher than pre-treatment levels (
p
< 0.05). KSS scores also improved after one month relative to pre-treatment levels (
p
< 0.01). This improvement was still present at three and six months after treatment in the corticosteroid group (
p
> 0.05). Patients treated with hylan GF20 showed lower scores in the last evaluation relative to month one (
p
< 0.05). No significant differences were observed between the treatment groups (
p
> 0.05).
Conclusions
Viscosupplementation increased functional scores in patients with severe osteoarthritis of the knee, especially within three months of injection. However, it was not superior to the use of triamcinolone. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 0341-2695 1432-5195 |
DOI: | 10.1007/s00264-017-3625-9 |